 Tunuguntla Kumar
Concepts (426)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Follicle Stimulating Hormone | 32 | 2022 | 216 | 5.000 |
Why?
| | Follicle Stimulating Hormone, beta Subunit | 22 | 2022 | 28 | 3.450 |
Why?
| | Luteinizing Hormone | 12 | 2022 | 169 | 2.010 |
Why?
| | Reproduction | 10 | 2019 | 179 | 1.760 |
Why?
| | Mice, Knockout | 36 | 2022 | 2586 | 1.520 |
Why?
| | Gonadotrophs | 3 | 2015 | 21 | 1.470 |
Why?
| | Ovary | 17 | 2018 | 191 | 1.420 |
Why?
| | Testis | 13 | 2016 | 133 | 1.400 |
Why?
| | Pituitary Gland | 8 | 2020 | 148 | 1.300 |
Why?
| | Mice, Transgenic | 26 | 2020 | 1956 | 1.130 |
Why?
| | Mice | 76 | 2022 | 14934 | 1.040 |
Why?
| | Ribonuclease III | 2 | 2015 | 34 | 0.990 |
Why?
| | DEAD-box RNA Helicases | 2 | 2015 | 56 | 0.970 |
Why?
| | Animals | 85 | 2022 | 31884 | 0.970 |
Why?
| | Gonadotropins | 5 | 2022 | 37 | 0.940 |
Why?
| | Fertility | 8 | 2015 | 130 | 0.940 |
Why?
| | Sertoli Cells | 8 | 2017 | 21 | 0.840 |
Why?
| | Receptors, FSH | 6 | 2018 | 9 | 0.830 |
Why?
| | Follicle Stimulating Hormone, Human | 2 | 2016 | 11 | 0.820 |
Why?
| | Biology | 2 | 2019 | 78 | 0.740 |
Why?
| | Inhibins | 13 | 2008 | 45 | 0.720 |
Why?
| | Protein Processing, Post-Translational | 3 | 2019 | 399 | 0.720 |
Why?
| | Signal Transduction | 13 | 2018 | 4527 | 0.720 |
Why?
| | Spermatogenesis | 4 | 2017 | 52 | 0.680 |
Why?
| | Laboratory Personnel | 1 | 2019 | 3 | 0.650 |
Why?
| | Genetics | 1 | 2019 | 27 | 0.640 |
Why?
| | Luteinizing Hormone, beta Subunit | 3 | 2007 | 4 | 0.600 |
Why?
| | Oogenesis | 1 | 2017 | 25 | 0.580 |
Why?
| | Ovarian Follicle | 8 | 2019 | 61 | 0.570 |
Why?
| | Gene Expression Regulation | 11 | 2019 | 2330 | 0.550 |
Why?
| | Recombinant Proteins | 4 | 2016 | 1237 | 0.540 |
Why?
| | Activin Receptors, Type II | 3 | 2005 | 9 | 0.530 |
Why?
| | Infertility | 3 | 2005 | 45 | 0.530 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2017 | 225 | 0.500 |
Why?
| | Models, Genetic | 1 | 2018 | 566 | 0.490 |
Why?
| | Integrases | 1 | 2015 | 116 | 0.480 |
Why?
| | PAX7 Transcription Factor | 1 | 2014 | 9 | 0.480 |
Why?
| | Female | 52 | 2022 | 59719 | 0.460 |
Why?
| | Epididymis | 2 | 2012 | 9 | 0.450 |
Why?
| | Gonadotropin-Releasing Hormone | 6 | 2022 | 188 | 0.450 |
Why?
| | Male | 47 | 2020 | 55813 | 0.440 |
Why?
| | Spermatozoa | 2 | 2010 | 84 | 0.440 |
Why?
| | Steroids | 4 | 2018 | 147 | 0.420 |
Why?
| | Gene Expression | 10 | 2020 | 1424 | 0.420 |
Why?
| | Glycoproteins | 7 | 2004 | 305 | 0.420 |
Why?
| | Infertility, Female | 6 | 2003 | 94 | 0.410 |
Why?
| | Infertility, Male | 4 | 2001 | 59 | 0.410 |
Why?
| | Granulosa Cells | 4 | 2019 | 29 | 0.410 |
Why?
| | Cyclin D3 | 1 | 2012 | 4 | 0.400 |
Why?
| | Cyclin D2 | 1 | 2012 | 4 | 0.400 |
Why?
| | Hypogonadism | 4 | 2014 | 75 | 0.400 |
Why?
| | Cyclin D1 | 1 | 2012 | 61 | 0.400 |
Why?
| | Glycoprotein Hormones, alpha Subunit | 4 | 2006 | 22 | 0.390 |
Why?
| | Inhibin-beta Subunits | 3 | 2007 | 5 | 0.390 |
Why?
| | Chorionic Gonadotropin | 4 | 2007 | 78 | 0.370 |
Why?
| | Real-Time Polymerase Chain Reaction | 4 | 2016 | 315 | 0.370 |
Why?
| | Stem Cells | 3 | 2014 | 547 | 0.370 |
Why?
| | History, 20th Century | 3 | 2019 | 269 | 0.360 |
Why?
| | Molecular Imaging | 1 | 2010 | 50 | 0.360 |
Why?
| | Models, Animal | 3 | 2006 | 349 | 0.350 |
Why?
| | Biological Evolution | 1 | 2014 | 415 | 0.350 |
Why?
| | Plasmodium berghei | 4 | 2016 | 7 | 0.350 |
Why?
| | Disease Models, Animal | 6 | 2012 | 3547 | 0.350 |
Why?
| | Aging | 4 | 2018 | 1624 | 0.340 |
Why?
| | Embryonic Development | 1 | 2010 | 117 | 0.340 |
Why?
| | Oocytes | 3 | 2018 | 171 | 0.340 |
Why?
| | Anti-Mullerian Hormone | 4 | 2019 | 50 | 0.340 |
Why?
| | Gonadotropins, Pituitary | 2 | 2005 | 22 | 0.320 |
Why?
| | Osteoporosis | 3 | 2017 | 225 | 0.310 |
Why?
| | Glycosylation | 3 | 2019 | 131 | 0.300 |
Why?
| | Pituitary Gland, Anterior | 4 | 1998 | 39 | 0.300 |
Why?
| | History, 21st Century | 2 | 2019 | 161 | 0.300 |
Why?
| | Androgens | 4 | 2012 | 167 | 0.280 |
Why?
| | Ovulation | 3 | 2014 | 39 | 0.270 |
Why?
| | Testicular Neoplasms | 3 | 2008 | 97 | 0.260 |
Why?
| | Receptors, Gonadotropin | 1 | 2005 | 1 | 0.260 |
Why?
| | Antimalarials | 3 | 2016 | 24 | 0.260 |
Why?
| | Mutation | 9 | 2008 | 3350 | 0.250 |
Why?
| | Sexual Behavior, Animal | 1 | 2005 | 48 | 0.250 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2006 | 345 | 0.250 |
Why?
| | Transgenes | 4 | 2016 | 170 | 0.250 |
Why?
| | Ovarian Neoplasms | 4 | 2008 | 387 | 0.250 |
Why?
| | Mice, Inbred C57BL | 16 | 2013 | 4718 | 0.240 |
Why?
| | MicroRNAs | 3 | 2017 | 604 | 0.240 |
Why?
| | Base Sequence | 9 | 2018 | 2120 | 0.240 |
Why?
| | RNA, Messenger | 12 | 2020 | 2563 | 0.240 |
Why?
| | Receptors, LHRH | 1 | 2003 | 14 | 0.230 |
Why?
| | Testosterone | 7 | 2013 | 343 | 0.230 |
Why?
| | Hormones | 1 | 2004 | 132 | 0.230 |
Why?
| | Freeze Drying | 1 | 2004 | 75 | 0.230 |
Why?
| | Receptors, Growth Factor | 2 | 2001 | 49 | 0.220 |
Why?
| | Liver | 4 | 2018 | 1688 | 0.220 |
Why?
| | Humans | 28 | 2022 | 115221 | 0.220 |
Why?
| | Adiposity | 2 | 2018 | 467 | 0.210 |
Why?
| | Blotting, Western | 2 | 2016 | 1150 | 0.210 |
Why?
| | Leydig Cells | 4 | 2004 | 11 | 0.210 |
Why?
| | Models, Biological | 4 | 2018 | 1638 | 0.200 |
Why?
| | Activins | 9 | 2020 | 26 | 0.200 |
Why?
| | Pharmaceutical Preparations | 1 | 2004 | 169 | 0.200 |
Why?
| | Genes, Dominant | 2 | 2013 | 94 | 0.190 |
Why?
| | Mice, Mutant Strains | 7 | 2013 | 272 | 0.190 |
Why?
| | gamma-Glutamyltransferase | 1 | 2000 | 42 | 0.180 |
Why?
| | Forkhead Box Protein L2 | 1 | 2020 | 2 | 0.180 |
Why?
| | Promoter Regions, Genetic | 4 | 2018 | 1133 | 0.180 |
Why?
| | Phenotype | 7 | 2007 | 2814 | 0.180 |
Why?
| | Biocompatible Materials | 1 | 2004 | 369 | 0.180 |
Why?
| | Smad4 Protein | 1 | 2020 | 34 | 0.180 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 2 | 2019 | 130 | 0.170 |
Why?
| | Receptors, Androgen | 3 | 2006 | 131 | 0.170 |
Why?
| | Genes, Lethal | 1 | 1999 | 26 | 0.170 |
Why?
| | Bone Morphogenetic Protein 15 | 2 | 2018 | 2 | 0.170 |
Why?
| | Growth Differentiation Factor 9 | 2 | 2018 | 4 | 0.170 |
Why?
| | Spiro Compounds | 1 | 2018 | 9 | 0.160 |
Why?
| | Genes, Tumor Suppressor | 2 | 1998 | 78 | 0.160 |
Why?
| | Oxidants | 1 | 1999 | 112 | 0.160 |
Why?
| | Receptors, Steroid | 1 | 2019 | 48 | 0.160 |
Why?
| | Antigens, Polyomavirus Transforming | 1 | 1998 | 14 | 0.160 |
Why?
| | Bone and Bones | 3 | 2013 | 282 | 0.160 |
Why?
| | Oligospermia | 2 | 2013 | 8 | 0.160 |
Why?
| | Esters | 1 | 2018 | 61 | 0.160 |
Why?
| | Neoplasms, Experimental | 2 | 1998 | 151 | 0.160 |
Why?
| | Texas | 1 | 2019 | 187 | 0.150 |
Why?
| | MDS1 and EVI1 Complex Locus Protein | 1 | 2018 | 6 | 0.150 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2018 | 106 | 0.150 |
Why?
| | Benzene Derivatives | 2 | 2012 | 8 | 0.150 |
Why?
| | Placentation | 1 | 2018 | 40 | 0.150 |
Why?
| | Bone Development | 1 | 2018 | 48 | 0.150 |
Why?
| | Oligopeptides | 1 | 1999 | 234 | 0.150 |
Why?
| | Phosphorylation | 3 | 2019 | 1574 | 0.140 |
Why?
| | Gene Transfer Techniques | 1 | 1998 | 147 | 0.140 |
Why?
| | Meiosis | 1 | 2017 | 59 | 0.140 |
Why?
| | Time Factors | 4 | 2016 | 6157 | 0.140 |
Why?
| | Thermogenesis | 1 | 2017 | 40 | 0.140 |
Why?
| | Aromatase | 3 | 2006 | 31 | 0.140 |
Why?
| | Pituitary Neoplasms | 1 | 1998 | 157 | 0.140 |
Why?
| | Gonads | 3 | 2007 | 21 | 0.140 |
Why?
| | Gene Targeting | 3 | 2007 | 75 | 0.140 |
Why?
| | Genital Neoplasms, Male | 1 | 1996 | 6 | 0.140 |
Why?
| | Adenoma | 1 | 1998 | 187 | 0.140 |
Why?
| | Osteoclasts | 2 | 2006 | 34 | 0.140 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2018 | 167 | 0.130 |
Why?
| | Microtubule-Associated Proteins | 1 | 2017 | 174 | 0.130 |
Why?
| | Equilibrative Nucleoside Transporter 1 | 1 | 2016 | 13 | 0.130 |
Why?
| | Growth Substances | 4 | 1998 | 137 | 0.130 |
Why?
| | Cattle | 2 | 2015 | 925 | 0.130 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2016 | 127 | 0.130 |
Why?
| | Colonic Neoplasms | 1 | 2018 | 222 | 0.130 |
Why?
| | Phagocytosis | 1 | 2017 | 352 | 0.130 |
Why?
| | Genital Neoplasms, Female | 1 | 1996 | 70 | 0.130 |
Why?
| | Autophagy | 1 | 2017 | 234 | 0.120 |
Why?
| | Cell Cycle | 3 | 2018 | 544 | 0.120 |
Why?
| | Wasting Syndrome | 3 | 2000 | 11 | 0.120 |
Why?
| | Metallothionein | 4 | 2003 | 24 | 0.120 |
Why?
| | Microscopy, Immunoelectron | 1 | 2014 | 43 | 0.120 |
Why?
| | Uterus | 3 | 2004 | 192 | 0.110 |
Why?
| | Triclosan | 2 | 2011 | 9 | 0.110 |
Why?
| | Superovulation | 3 | 2006 | 8 | 0.110 |
Why?
| | Pituitary Hormones | 1 | 2013 | 16 | 0.110 |
Why?
| | Pregnancy | 4 | 2018 | 5525 | 0.110 |
Why?
| | Molecular Sequence Data | 4 | 2006 | 2797 | 0.110 |
Why?
| | Osteocalcin | 1 | 2013 | 34 | 0.110 |
Why?
| | Adipose Tissue | 1 | 2017 | 558 | 0.110 |
Why?
| | Dihydrotestosterone | 1 | 1993 | 39 | 0.110 |
Why?
| | Thioctic Acid | 1 | 2013 | 10 | 0.110 |
Why?
| | Malaria | 2 | 2011 | 48 | 0.110 |
Why?
| | Bone Resorption | 3 | 2013 | 73 | 0.110 |
Why?
| | Microscopy, Confocal | 1 | 2014 | 305 | 0.110 |
Why?
| | Malaria, Falciparum | 1 | 2012 | 25 | 0.110 |
Why?
| | Organ Specificity | 3 | 2012 | 270 | 0.110 |
Why?
| | Rats | 4 | 2014 | 4980 | 0.100 |
Why?
| | Protozoan Proteins | 2 | 2013 | 62 | 0.100 |
Why?
| | Testicular Hormones | 2 | 2003 | 9 | 0.100 |
Why?
| | Urea | 1 | 2012 | 68 | 0.100 |
Why?
| | Biomedical Research | 1 | 2018 | 585 | 0.100 |
Why?
| | Apoptosis | 2 | 2017 | 2368 | 0.100 |
Why?
| | Estradiol | 2 | 2008 | 455 | 0.100 |
Why?
| | Sequence Homology, Nucleic Acid | 2 | 2017 | 152 | 0.100 |
Why?
| | Host-Parasite Interactions | 1 | 2013 | 97 | 0.100 |
Why?
| | Sex Factors | 3 | 2006 | 1722 | 0.100 |
Why?
| | Castration | 2 | 2003 | 14 | 0.100 |
Why?
| | Ki-67 Antigen | 1 | 2012 | 104 | 0.100 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2013 | 192 | 0.100 |
Why?
| | Analysis of Variance | 1 | 2014 | 1231 | 0.090 |
Why?
| | Pancreas | 1 | 2013 | 280 | 0.090 |
Why?
| | Epithelium | 1 | 2012 | 297 | 0.090 |
Why?
| | Ovariectomy | 3 | 2017 | 117 | 0.090 |
Why?
| | Sperm Motility | 1 | 2010 | 26 | 0.090 |
Why?
| | Osteoblasts | 2 | 2013 | 106 | 0.090 |
Why?
| | Anti-Infective Agents, Local | 1 | 2011 | 40 | 0.090 |
Why?
| | Amino Acid Sequence | 4 | 2013 | 1990 | 0.090 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 2010 | 44 | 0.090 |
Why?
| | Seminal Vesicles | 2 | 2000 | 8 | 0.090 |
Why?
| | Radioimmunoassay | 2 | 2004 | 163 | 0.090 |
Why?
| | Embryo, Mammalian | 1 | 2010 | 214 | 0.090 |
Why?
| | Adipocytes | 3 | 2018 | 189 | 0.090 |
Why?
| | Insulin-Like Growth Factor I | 3 | 2006 | 286 | 0.090 |
Why?
| | Neoplasm Proteins | 2 | 2018 | 386 | 0.080 |
Why?
| | Orchiectomy | 3 | 1995 | 57 | 0.080 |
Why?
| | Homozygote | 3 | 1999 | 188 | 0.080 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2010 | 271 | 0.080 |
Why?
| | Pseudopregnancy | 1 | 2009 | 3 | 0.080 |
Why?
| | Polymerase Chain Reaction | 2 | 2009 | 1000 | 0.080 |
Why?
| | Microinjections | 1 | 2009 | 77 | 0.080 |
Why?
| | Longevity | 2 | 2008 | 137 | 0.080 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2008 | 24 | 0.080 |
Why?
| | Hyperphagia | 1 | 2008 | 28 | 0.080 |
Why?
| | Plasmodium falciparum | 1 | 2008 | 27 | 0.080 |
Why?
| | Microscopy, Electron | 3 | 2013 | 410 | 0.080 |
Why?
| | Genes, Reporter | 1 | 2009 | 257 | 0.080 |
Why?
| | Kinetics | 2 | 2018 | 1558 | 0.080 |
Why?
| | Antineoplastic Agents | 1 | 2018 | 1882 | 0.080 |
Why?
| | Cell Line, Tumor | 3 | 2018 | 2715 | 0.070 |
Why?
| | Chorionic Gonadotropin, beta Subunit, Human | 2 | 2006 | 14 | 0.070 |
Why?
| | Ribonucleoproteins, Small Nucleolar | 1 | 2006 | 3 | 0.070 |
Why?
| | Spermatogonia | 1 | 2006 | 11 | 0.070 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2006 | 64 | 0.070 |
Why?
| | 3' Flanking Region | 1 | 2006 | 7 | 0.070 |
Why?
| | Codon, Terminator | 1 | 2006 | 21 | 0.070 |
Why?
| | Preoptic Area | 1 | 2005 | 5 | 0.060 |
Why?
| | Copulation | 1 | 2005 | 5 | 0.060 |
Why?
| | Bone Marrow Cells | 1 | 2006 | 267 | 0.060 |
Why?
| | Genes | 2 | 1995 | 224 | 0.060 |
Why?
| | Penis | 1 | 2005 | 37 | 0.060 |
Why?
| | Cyclic AMP | 2 | 2003 | 226 | 0.060 |
Why?
| | Mice, Inbred ICR | 2 | 2003 | 109 | 0.060 |
Why?
| | Olfactory Pathways | 1 | 2005 | 56 | 0.060 |
Why?
| | Nitric Oxide Synthase | 1 | 2005 | 209 | 0.060 |
Why?
| | Cell Proliferation | 1 | 2012 | 2192 | 0.060 |
Why?
| | Cloning, Molecular | 2 | 1995 | 524 | 0.060 |
Why?
| | Gene Deletion | 4 | 2013 | 356 | 0.060 |
Why?
| | CHO Cells | 1 | 2004 | 138 | 0.060 |
Why?
| | Protein Subunits | 3 | 2014 | 201 | 0.060 |
Why?
| | Genetic Markers | 1 | 2005 | 323 | 0.060 |
Why?
| | Thyrotropin | 1 | 2004 | 99 | 0.060 |
Why?
| | Cricetinae | 1 | 2004 | 259 | 0.060 |
Why?
| | Hypothyroidism | 1 | 2004 | 66 | 0.060 |
Why?
| | Peptides | 3 | 2000 | 849 | 0.060 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2006 | 311 | 0.060 |
Why?
| | Biological Assay | 1 | 2004 | 113 | 0.060 |
Why?
| | DNA Damage | 1 | 2006 | 357 | 0.060 |
Why?
| | Reference Values | 1 | 2005 | 748 | 0.060 |
Why?
| | Serum | 1 | 2004 | 57 | 0.060 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2004 | 192 | 0.060 |
Why?
| | Fibrin | 1 | 2004 | 65 | 0.060 |
Why?
| | Thecoma | 1 | 2003 | 2 | 0.060 |
Why?
| | Hypothalamus | 1 | 2003 | 147 | 0.050 |
Why?
| | Dimerization | 1 | 2003 | 176 | 0.050 |
Why?
| | Organ Size | 3 | 2013 | 444 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 928 | 0.050 |
Why?
| | United States | 1 | 2018 | 12256 | 0.050 |
Why?
| | Protein Binding | 2 | 2018 | 1898 | 0.050 |
Why?
| | Phylogeny | 1 | 2006 | 796 | 0.050 |
Why?
| | Cells, Cultured | 3 | 2017 | 3897 | 0.050 |
Why?
| | Growth Inhibitors | 1 | 2001 | 44 | 0.050 |
Why?
| | Wound Healing | 1 | 2004 | 259 | 0.050 |
Why?
| | Sperm Count | 1 | 2001 | 16 | 0.050 |
Why?
| | Obesity | 2 | 2017 | 2525 | 0.050 |
Why?
| | Protein Conformation | 1 | 2004 | 811 | 0.050 |
Why?
| | In Situ Nick-End Labeling | 1 | 2001 | 119 | 0.050 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2006 | 1138 | 0.050 |
Why?
| | Sex Characteristics | 2 | 1998 | 639 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2018 | 401 | 0.050 |
Why?
| | Cell Line | 5 | 2017 | 2645 | 0.050 |
Why?
| | Drug Delivery Systems | 1 | 2004 | 296 | 0.050 |
Why?
| | Motor Activity | 1 | 2005 | 643 | 0.050 |
Why?
| | Liver Regeneration | 1 | 2000 | 32 | 0.040 |
Why?
| | Growth Hormone | 1 | 2000 | 103 | 0.040 |
Why?
| | Sequence Analysis, DNA | 2 | 2013 | 728 | 0.040 |
Why?
| | Growth Disorders | 1 | 2000 | 78 | 0.040 |
Why?
| | Homeostasis | 1 | 2003 | 578 | 0.040 |
Why?
| | Tissue Culture Techniques | 1 | 2020 | 66 | 0.040 |
Why?
| | Follistatin | 4 | 2001 | 12 | 0.040 |
Why?
| | Transcription, Genetic | 3 | 2018 | 1317 | 0.040 |
Why?
| | Acetylcysteine | 1 | 2000 | 142 | 0.040 |
Why?
| | tert-Butylhydroperoxide | 1 | 1999 | 10 | 0.040 |
Why?
| | Lethal Dose 50 | 1 | 1999 | 12 | 0.040 |
Why?
| | Cysteine | 1 | 2000 | 171 | 0.040 |
Why?
| | Mutagens | 1 | 1999 | 17 | 0.040 |
Why?
| | Fetal Death | 1 | 1999 | 50 | 0.040 |
Why?
| | Crosses, Genetic | 1 | 1999 | 140 | 0.040 |
Why?
| | 3T3-L1 Cells | 1 | 2018 | 31 | 0.040 |
Why?
| | Urinary Tract | 1 | 1999 | 37 | 0.040 |
Why?
| | Vibrissae | 1 | 1998 | 10 | 0.040 |
Why?
| | Cell Shape | 1 | 2018 | 54 | 0.040 |
Why?
| | Gene Expression Profiling | 2 | 2017 | 1524 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2004 | 1635 | 0.040 |
Why?
| | Smad3 Protein | 1 | 2018 | 41 | 0.040 |
Why?
| | Smad2 Protein | 1 | 2018 | 33 | 0.040 |
Why?
| | Curcumin | 1 | 2018 | 29 | 0.040 |
Why?
| | Hydrolysis | 1 | 2018 | 174 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2018 | 1145 | 0.040 |
Why?
| | Histone Code | 1 | 2018 | 28 | 0.040 |
Why?
| | Fluorescence | 1 | 2018 | 148 | 0.040 |
Why?
| | Embryonic and Fetal Development | 2 | 1995 | 94 | 0.040 |
Why?
| | Spectrometry, Fluorescence | 1 | 2018 | 157 | 0.040 |
Why?
| | Snail Family Transcription Factors | 1 | 2018 | 19 | 0.040 |
Why?
| | Brain Stem | 1 | 1998 | 101 | 0.040 |
Why?
| | Acetylation | 1 | 2018 | 211 | 0.040 |
Why?
| | Isoenzymes | 1 | 1998 | 286 | 0.040 |
Why?
| | Adipose Tissue, Beige | 1 | 2017 | 2 | 0.040 |
Why?
| | DNA | 2 | 1995 | 1353 | 0.040 |
Why?
| | Uncoupling Protein 1 | 1 | 2017 | 16 | 0.040 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2017 | 55 | 0.040 |
Why?
| | Gonadotropins, Equine | 1 | 1997 | 3 | 0.040 |
Why?
| | Haploinsufficiency | 1 | 2017 | 44 | 0.040 |
Why?
| | Cell Death | 1 | 2018 | 324 | 0.040 |
Why?
| | Adipose Tissue, White | 1 | 2017 | 33 | 0.040 |
Why?
| | Polycystic Ovary Syndrome | 1 | 1999 | 141 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2018 | 299 | 0.030 |
Why?
| | Superoxide Dismutase | 1 | 1998 | 305 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2018 | 332 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2018 | 443 | 0.030 |
Why?
| | Tritium | 1 | 2016 | 68 | 0.030 |
Why?
| | Uridine | 1 | 2016 | 29 | 0.030 |
Why?
| | Inhibitory Concentration 50 | 1 | 2016 | 75 | 0.030 |
Why?
| | Cell Nucleus | 1 | 2018 | 556 | 0.030 |
Why?
| | Genes, Retinoblastoma | 1 | 1995 | 8 | 0.030 |
Why?
| | Diet, High-Fat | 1 | 2017 | 225 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2018 | 524 | 0.030 |
Why?
| | Cell Differentiation | 4 | 2006 | 1700 | 0.030 |
Why?
| | Growth | 1 | 1996 | 56 | 0.030 |
Why?
| | RNA Interference | 1 | 2017 | 437 | 0.030 |
Why?
| | Blotting, Southern | 1 | 1995 | 68 | 0.030 |
Why?
| | Genes, p53 | 1 | 1995 | 61 | 0.030 |
Why?
| | Down-Regulation | 1 | 2018 | 599 | 0.030 |
Why?
| | Blotting, Northern | 1 | 1995 | 193 | 0.030 |
Why?
| | Substrate Specificity | 1 | 2016 | 355 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1995 | 353 | 0.030 |
Why?
| | Antibodies | 1 | 2017 | 372 | 0.030 |
Why?
| | Introns | 1 | 1995 | 227 | 0.030 |
Why?
| | Hemorrhage | 1 | 1999 | 618 | 0.030 |
Why?
| | Exons | 1 | 1995 | 301 | 0.030 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 1996 | 349 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2004 | 1481 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 2017 | 590 | 0.030 |
Why?
| | Adenosine | 1 | 2016 | 204 | 0.030 |
Why?
| | Body Weight | 2 | 2008 | 875 | 0.030 |
Why?
| | Mice, 129 Strain | 1 | 2013 | 76 | 0.030 |
Why?
| | Immunoblotting | 1 | 1993 | 282 | 0.030 |
Why?
| | Desmocollins | 1 | 2012 | 2 | 0.030 |
Why?
| | DNA Primers | 1 | 2013 | 515 | 0.030 |
Why?
| | Amino Acid Substitution | 1 | 2013 | 262 | 0.030 |
Why?
| | Saccharomyces cerevisiae | 1 | 2016 | 477 | 0.030 |
Why?
| | Mice, Inbred C3H | 2 | 2006 | 242 | 0.030 |
Why?
| | In Vitro Techniques | 2 | 2006 | 1036 | 0.030 |
Why?
| | Species Specificity | 1 | 1993 | 549 | 0.020 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2013 | 164 | 0.020 |
Why?
| | Drug Discovery | 1 | 2012 | 124 | 0.020 |
Why?
| | Mitochondria | 1 | 2017 | 750 | 0.020 |
Why?
| | Survival Analysis | 2 | 2008 | 1215 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2018 | 1046 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2012 | 171 | 0.020 |
Why?
| | Genetic Association Studies | 1 | 2013 | 344 | 0.020 |
Why?
| | Plasmodium | 1 | 2011 | 9 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2013 | 590 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2012 | 458 | 0.020 |
Why?
| | Rodentia | 1 | 2011 | 44 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2003 | 799 | 0.020 |
Why?
| | Flagella | 1 | 2010 | 18 | 0.020 |
Why?
| | NF-kappa B | 2 | 2006 | 637 | 0.020 |
Why?
| | Transcription Factors | 2 | 2012 | 1531 | 0.020 |
Why?
| | Membrane Glycoproteins | 1 | 2012 | 429 | 0.020 |
Why?
| | Cell Division | 2 | 2003 | 759 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2010 | 339 | 0.020 |
Why?
| | RNA | 1 | 1995 | 810 | 0.020 |
Why?
| | Parasitemia | 1 | 2008 | 9 | 0.020 |
Why?
| | Mutagenesis, Insertional | 1 | 2008 | 61 | 0.020 |
Why?
| | Disease Progression | 2 | 2008 | 2390 | 0.020 |
Why?
| | Absorptiometry, Photon | 1 | 2008 | 223 | 0.020 |
Why?
| | Cachexia | 1 | 2008 | 52 | 0.020 |
Why?
| | Corpus Luteum | 1 | 2007 | 19 | 0.020 |
Why?
| | Syndrome | 1 | 2008 | 338 | 0.020 |
Why?
| | TATA-Binding Protein Associated Factors | 1 | 2007 | 15 | 0.020 |
Why?
| | Glucose Tolerance Test | 1 | 2008 | 344 | 0.020 |
Why?
| | Leptin | 1 | 2008 | 212 | 0.020 |
Why?
| | Transcription Factor TFIID | 1 | 2007 | 21 | 0.020 |
Why?
| | Checkpoint Kinase 2 | 1 | 2006 | 21 | 0.020 |
Why?
| | Protein Phosphatase 2C | 1 | 2006 | 14 | 0.020 |
Why?
| | Checkpoint Kinase 1 | 1 | 2006 | 28 | 0.020 |
Why?
| | Protein Phosphatase 1 | 1 | 2006 | 28 | 0.020 |
Why?
| | GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2006 | 3 | 0.020 |
Why?
| | Eating | 1 | 2008 | 347 | 0.020 |
Why?
| | Ascorbic Acid | 1 | 2006 | 110 | 0.020 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2006 | 262 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 157 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2007 | 746 | 0.020 |
Why?
| | Centrosome | 1 | 2004 | 59 | 0.010 |
Why?
| | Protein Kinases | 1 | 2006 | 307 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2006 | 791 | 0.010 |
Why?
| | Cell Polarity | 1 | 2004 | 131 | 0.010 |
Why?
| | Energy Metabolism | 1 | 2008 | 730 | 0.010 |
Why?
| | Insulin | 1 | 2013 | 2083 | 0.010 |
Why?
| | Estrogens | 1 | 2006 | 317 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2011 | 2806 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2007 | 696 | 0.010 |
Why?
| | Cell Adhesion | 1 | 2004 | 430 | 0.010 |
Why?
| | Transcription Initiation Site | 1 | 2003 | 40 | 0.010 |
Why?
| | Hypertrophy | 1 | 2003 | 112 | 0.010 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2006 | 447 | 0.010 |
Why?
| | Transcription Factor AP-2 | 1 | 2003 | 81 | 0.010 |
Why?
| | Neoplasms | 1 | 1996 | 2106 | 0.010 |
Why?
| | Point Mutation | 1 | 2003 | 217 | 0.010 |
Why?
| | Progesterone | 1 | 2003 | 232 | 0.010 |
Why?
| | Enzymes | 1 | 2001 | 62 | 0.010 |
Why?
| | Multigene Family | 1 | 2001 | 194 | 0.010 |
Why?
| | Transfection | 1 | 2003 | 872 | 0.010 |
Why?
| | Stomach Diseases | 1 | 2000 | 19 | 0.010 |
Why?
| | Binding Sites | 1 | 2003 | 1173 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 2003 | 753 | 0.010 |
Why?
| | Trigeminal Nerve | 1 | 1998 | 28 | 0.010 |
Why?
| | Heterozygote | 1 | 1998 | 251 | 0.010 |
Why?
| | Liver Diseases | 1 | 2000 | 263 | 0.010 |
Why?
| | Axons | 1 | 1998 | 179 | 0.010 |
Why?
| | Follicular Cyst | 1 | 1996 | 1 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2003 | 1318 | 0.010 |
Why?
| | Activin Receptors | 1 | 1995 | 3 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 1998 | 616 | 0.010 |
Why?
| | Palate | 1 | 1995 | 28 | 0.010 |
Why?
| | Mandible | 1 | 1995 | 63 | 0.010 |
Why?
| | Skull | 1 | 1995 | 118 | 0.010 |
Why?
| | Middle Aged | 1 | 2013 | 26872 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 1997 | 2216 | 0.010 |
Why?
| | Transforming Growth Factor beta | 1 | 1995 | 448 | 0.010 |
Why?
| | Adult | 1 | 2013 | 30710 | 0.010 |
Why?
| | Biomarkers | 1 | 2001 | 3422 | 0.010 |
Why?
| | Neurons | 1 | 1998 | 1285 | 0.010 |
Why?
|
|
Kumar's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|